LINOLEIC ACID OR ALPHA-LINOLENIC ACID FOR USE IN REDUCING COGNITIVE DISORDERS/EARLY NEUROGENESIS INDUCED BY EARLY LIFE STRESS Russian patent published in 2021 - IPC A61K31/201 A61K31/202 A61P25/00 

FIELD: food industry.

SUBSTANCE: group of inventions relates to the use of linoleic acid (LA) and alpha-linolenic acid (ALA) for preparing a composition, including LA and ALA in weight ratio LA/ALA in range of 0.1–12, for prevention of cognitive function reduction induced by early life human stress, where the human being is an unborn fetus, an infant or toddler, and to prevent the early life (ES) induced cell hippocampus decline in a human, where a human being is an unborn fetus, an infant or toddler.

EFFECT: group of inventions provides a composition comprising linoleic acid (LA) and alpha-linolenic acid (ALA) in a low weight ratio of LA/ALA, which helps to prevent cognitive function reduction induced by stress in early life, also helps to reduce early stage induced neurogenesis, and also promotes the survival of hippocampal cells.

15 cl, 1 dwg, 3 tbl, 2 ex